Development of monoclonal antibodies with specificity to oral squamous cell carcinoma
Author:
- 1 October 1991
- journal article
- Published by Wiley in The Laryngoscope
- Vol. 101 (10) , 1076-1080
Abstract
A panel of five monoclonal antibodies have been produced that show binding when directed against human oral head and neck squamous cell carcinomas. These monoclonal antibodies are derived from antibody‐secreting cells obtained using cell hybridization techniques. The activity of the antibody was tested in vitro against oral head and neck squamous cell carcinoma (n = 10). Control groups included normal oral mucosa (n = 7), hyperkeratosis (n = 5), mild dysplasia (n = 4), and severe dysplasia (n = 3). Results using immunoperoxidase staining confirmed the binding of the five monoclonal antibodies to human head and neck squamous cell carcinoma cells, with predominant reactivity (50% to 90%) in the majority of the specimens, compared with negative (0%) to weak (<5%) or focal (5% to <50%) reactivity in the control specimens.Keywords
This publication has 10 references indexed in Scilit:
- A clinical trial of anti-idiotype therapy for B cell malignancyBlood, 1985
- Pilot trial of murine monoclonal antibodies in patients with advanced melanoma.Journal of Clinical Oncology, 1985
- Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.Proceedings of the National Academy of Sciences, 1985
- Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody.Journal of Clinical Oncology, 1984
- Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukemiaBlood, 1982
- PHASE-I CLINICAL TRIAL OF MONOCLONAL ANTIBODY IN TREATMENT OF GASTROINTESTINAL TUMOURSThe Lancet, 1982
- In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemiaBlood, 1981
- Differentiation between B cells, T cells, and histiocytes in melanocytic lesions: Primary and metastatic melanoma and halo and giant pigmented neviClinical Immunology and Immunopathology, 1975
- Delayed Cutaneous Sensitivity Reactions to Extracts of Autologous Malignant Melanoma: A Second Look2JNCI: Journal of the National Cancer Institute, 1972
- Transport d'agents cytostatiques par les protéines plasmatiques: III. Activité antitumorale in vitro de conjugués cytostatique-azoprotéinesEuropean Journal of Cancer (1965), 1969